About us
Products
Careers
Investor Relations
News
Cares
Language:
- Italiano
- English

Pharmanutra 2019 Interim Results – CFO SIM

Published: 04 November 2019 14:47

<< Articolo precedente Next Article >>

Related News

Four new distribution agreements in EU, Asia...

Despite the COVID-19 emergency, the PharmaNutra Group is still strengthening its international presence...
Mediobanca starts PharmaNutra share cover...

Publication of the start of coverage survey drafted by Mediobanca; declaring a target price at €24.50. PharmaNutra...

Related Products

Novomega

Nutritional supplement containing EPA and DHA aimed at treating alimentary deficiency or as a complement...
CardioSiderAL

CardioSideral® is a nutritional supplement that contains Sucrosomial® Iron (Sideral r.m®), vitamin...

Pharmanutra SpA is a pharmaceutical company based in Pisa. It was founded in 2003 with the aim of developing nutraceuticals and medical devices. Pharmanutra follows rigorous standards of quality by maintaining a high attention to the raw materials used, unique and exclusive for the whole national territory.

PharmaNutra Spa | Registered office

Via Delle Lenze, 216/b

56122 Pisa

Tel. +39 050 7846500

Fax +39 050 7846524

C.F. / P.Iva / Reg. Impr. 01679440501

Codice Destinatario Fatturazione Elettronica SUBM70N

Cap.Soc. € 1.123.097,70

I.V. | REA 146259

Privacy policy
Cookie policy
General conditions
Code of ethics
Mod. 231

NEWSLETTER

Subscribe to the Pharmanutra newsletter and you will be constantly updated on all our activities.

Read Newsletter Disclosure

AWARDS

QUALITY

© Copyright - PHARMANUTRA.IT

All Rights Reserved.

This site is set to allow the use of all cookies in order to ensure a better navigation. If you continue to browse, you accept our cookies use. Read More